DIANT Pharma develops continuous processing technology for nanoparticle drug products and vaccines. They utilize a proprietary and continuous ethanol-injection system to form nanoparticles with controlled particle sizes at high flow rates, providing pharmaceutical companies with a continuous drug encapsulation technique to achieve their goals and high encapsulation processes. Founded in 2019, DIANT offers technology that is robust and reliable from R&D to manufacturing over a product’s lifespan.

DIANT Pharma

Pharmaceutical

Connecticut Innovations provides strategic capital and operational insight to push the frontiers of high-tech industries such as energy, biotechnology, information technology, and photonics. Over the years, CI has helped over 100 emerging companies research, develop, and market new products and services. This activity has attracted over $1 billion dollars in additional investments from private equity providers. CI has brought the State of Connecticut over $510 million in Gross State Profit and over 5,000 additional job-years.

Connecticut Innovations

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Hello,
In 5 quick steps, tell us about the type of opportunities you'd be interested in next. We'll use this information to connect you to relevant opportunities in the Connecticut Innovations , Inc. network as they come up. You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Connecticut Innovations , Inc. company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Career Opportunities